These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]. Asai M; Shirotani K; Kondo T; Inoue H; Iwata N Nihon Yakurigaku Zasshi; 2014 Jan; 143(1):23-6. PubMed ID: 24420133 [No Abstract] [Full Text] [Related]
8. Alterations of ATG4A and LC3B in neurons derived from Alzheimer's disease patients. Shirotani K; Watanabe K; Hatta D; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N Genes Cells; 2023 Apr; 28(4):319-325. PubMed ID: 36719634 [TBL] [Abstract][Full Text] [Related]
9. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons. Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452 [TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells. Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781 [TBL] [Abstract][Full Text] [Related]
11. Endogenous Docosahexaenoic Acid (DHA) Prevents Aβ1-42 Oligomer-Induced Neuronal Injury. Tan Y; Ren H; Shi Z; Yao X; He C; Kang JX; Wan JB; Li P; Yuan TF; Su H Mol Neurobiol; 2016 Jul; 53(5):3146-3153. PubMed ID: 26021747 [TBL] [Abstract][Full Text] [Related]
12. Targeting Hsc70-based autophagy to eliminate amyloid β oligomers. Dou J; Su P; Xu C; Wen Z; Mao Z; Li W Biochem Biophys Res Commun; 2020 Apr; 524(4):923-928. PubMed ID: 32057360 [TBL] [Abstract][Full Text] [Related]
13. iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome. Mendivil-Perez M; Velez-Pardo C; Kosik KS; Lopera F; Jimenez-Del-Rio M Neurosci Lett; 2019 Jun; 703():111-118. PubMed ID: 30904577 [TBL] [Abstract][Full Text] [Related]
14. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. Kondo T; Imamura K; Funayama M; Tsukita K; Miyake M; Ohta A; Woltjen K; Nakagawa M; Asada T; Arai T; Kawakatsu S; Izumi Y; Kaji R; Iwata N; Inoue H Cell Rep; 2017 Nov; 21(8):2304-2312. PubMed ID: 29166618 [TBL] [Abstract][Full Text] [Related]
16. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Zhang D; Pekkanen-Mattila M; Shahsavani M; Falk A; Teixeira AI; Herland A Biomaterials; 2014 Feb; 35(5):1420-8. PubMed ID: 24290439 [TBL] [Abstract][Full Text] [Related]
17. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease. Sahlgren Bendtsen KM; Hall VJ Cells; 2023 Jan; 12(3):. PubMed ID: 36766763 [TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079 [TBL] [Abstract][Full Text] [Related]
20. Probing the therapeutic potential of TRPC6 for Alzheimer's disease in live neurons from patient-specific iPSCs. Tao R; Lu R; Wang J; Zeng S; Zhang T; Guo W; Zhang X; Cheng Q; Yue C; Wang Y; Jing N J Mol Cell Biol; 2020 Oct; 12(10):807-816. PubMed ID: 32492143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]